Last year (our 2005 edition), Pfizer was 47% ahead of its closest competitor in drug revenues ($46 billion to $31 billion), but that margin was shaved to 30% in 2005 as Pfizer sales dropped 4%.
Our editorial staff has gathered information from annual reports, interviews, and analyst coverage to compile a list of the previous year's Top 20 players in the Pharma arena.